Tema Heart & Health ETF (NASDAQ:HRTS – Get Free Report) shares dropped 3.3% during mid-day trading on Thursday. The stock traded as low as $38.47 and last traded at $38.5110. 6,008 shares traded hands during trading, an increase of 18% from the average daily volume of 5,088 shares. The stock had previously closed at $39.84.
Tema Heart & Health ETF Stock Performance
The company’s fifty day moving average is $36.97 and its two-hundred day moving average is $35.63. The firm has a market cap of $57.00 million, a price-to-earnings ratio of 29.47 and a beta of 0.60.
Institutional Investors Weigh In On Tema Heart & Health ETF
A number of large investors have recently modified their holdings of HRTS. Royal Bank of Canada lifted its position in Tema Heart & Health ETF by 8.8% during the 1st quarter. Royal Bank of Canada now owns 21,083 shares of the company’s stock worth $710,000 after acquiring an additional 1,703 shares in the last quarter. XML Financial LLC acquired a new stake in Tema Heart & Health ETF in the second quarter valued at approximately $223,000. Anson Capital Inc. purchased a new stake in shares of Tema Heart & Health ETF during the second quarter valued at approximately $297,000. Members Advisory Group LLC purchased a new stake in shares of Tema Heart & Health ETF during the second quarter valued at approximately $398,000. Finally, Rothschild Capital Partners LLC purchased a new stake in shares of Tema Heart & Health ETF during the second quarter valued at approximately $651,000.
Tema Heart & Health ETF Company Profile
The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.
Further Reading
- Five stocks we like better than Tema Heart & Health ETF
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Tema Heart & Health ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Heart & Health ETF and related companies with MarketBeat.com's FREE daily email newsletter.
